Explore the significance of MRD negativity in cancer prognosis and its implications for treatment strategies in community-based practices.
Mitul Gandhi, MD
Advertisement
Articles by Mitul Gandhi, MD
Mitul Gandhi, MD, discusses the current landscape for patients with diffuse large B-cell lymphoma and what may be coming in the future.
Advertisement
Latest Updated Articles
How MRD Is Used to Interpret Novel TherapiesPublished: December 11th 2025 | Updated:
Advertisement
Advertisement
Trending on Targeted Oncology - Immunotherapy, Biomarkers, and Cancer Pathways
1
FDA Approves T-DXd Plus Pertuzumab for HER2-Positive Breast Cancer
2
Teclistamab/Daratumumab Earns FDA Priority Voucher for R/R Myeloma
3
Roxadustat Granted Orphan Drug Designation for Myelodysplastic Syndromes
4
FDA Fast-Tracks Muzastotug Combo in MSS Metastatic Colorectal Cancer
5
